Will the routine blood test be abnormal for pancreatic cancer?

Written by Yan Chun
Oncology
Updated on May 22, 2025
00:00
00:00

Pancreatic cancer is a malignant tumor of the digestive system. In the early stages, most pancreatic cancer patients generally have normal routine blood test indicators and show no abnormalities. This is because the early lesions are localized, without invasion or metastasis, and therefore have minimal impact on the overall body, not causing abnormalities in routine blood test indicators. As the disease progresses, patients in the middle and late stages of pancreatic cancer often exhibit abnormalities in routine blood test indicators, mainly manifested as abnormalities in hemoglobin levels. Patients experience mild, moderate, or severe anemia. Some patients may also have metastasis to the bone marrow, liver, spleen, etc. Clinically, there can also be a decrease in white blood cells and platelets. Due to the impact of pancreatic cancer lesions on liver function, there can also be abnormalities in coagulation function.

Other Voices

doctor image
home-news-image
Written by Liu Liang
Oncology
50sec home-news-image

Dietary Taboos for Patients with Pancreatic Cancer

Regarding the dietary restrictions for pancreatic cancer patients, there are no specific prohibitions. The main recommendation is to avoid what we typically refer to as junk food, such as barbecued foods and pickled products. Aside from avoiding these foods, it is important to focus on a nutritious and balanced diet, with a good mix of both meat and vegetables. Additionally, because pancreatic cancer patients may experience symptoms like abdominal pain, nausea, vomiting, and a feeling of fullness or discomfort in the upper abdomen, the diet should primarily consist of light and easily digestible foods. In doing so, while ensuring that the patient receives sufficient nutrition, it is best to consume foods that are easy to digest and nutritionally balanced.

doctor image
home-news-image
Written by Sun Ming Yue
Medical Oncology
59sec home-news-image

Classification of the Malignancy of Pancreatic Cancer

Pancreatic cancer can also be described as a malignant tumor occurring in the pancreas, generally with a high malignancy level, resulting in a higher probability of patient death. To understand the classification of pancreatic cancer, it can be categorized based on the location of occurrence within the pancreas and the pathological type. Based on the location of occurrence, pancreatic cancer can generally be divided into cancers of the pancreatic head, body, tail, and entire pancreas. According to the pathological types of pancreatic cancer, it can be classified into ductal adenocarcinoma, and also some special types of ductal-origin cancers, which generally include pleomorphic carcinoma, mucinous carcinoma, adenosquamous carcinoma, mucinous cystadenocarcinoma, and signet ring cell carcinoma, among others.

doctor image
home-news-image
Written by Yan Chun
Oncology
1min 9sec home-news-image

Does pancreatic cancer cause bloody stools?

Patients with pancreatic cancer may exhibit clinical symptoms of bloody stools, and the possible causes are as follows: First, the lesion of pancreatic cancer invades organs and tissues such as the gastrointestinal tract, causing damage to the mucous membranes, which clinically results in bloody stools. Second, if the pancreatic cancer metastasizes to the liver, liver function is impaired. Some patients may develop hyperactive splenic function, leading to a decline in platelet counts. When platelet levels drop to a certain extent, spontaneous visceral bleeding can occur, which may also manifest as bloody stools clinically. Third, in the late stages of pancreatic cancer, the disease may cause metastasis to multiple organs, leading to the complication of disseminated intravascular coagulation. This results in impaired coagulation function, making gastrointestinal bleeding likely, which is also clinically manifested as bloody stools.

doctor image
home-news-image
Written by Yan Chun
Oncology
1min 1sec home-news-image

Can patients with advanced pancreatic cancer eat watermelon?

Patients with advanced pancreatic cancer can eat watermelon. This is because many patients with advanced pancreatic cancer experience liver metastasis. Cancerous tissues damage liver cells, leading to impaired liver function and abnormal glycogen metabolism. Many patients may experience episodes of hypoglycemia, and eating watermelon can help replenish blood sugar, which is beneficial for the patients. Additionally, many patients with advanced pancreatic cancer suffer from a decline in appetite, and watermelon can stimulate their appetite and increase their food intake, which is also beneficial for their recovery. Thirdly, watermelon has a certain diuretic effect. Since many patients with advanced pancreatic cancer also suffer from hypoproteinemia, they are prone to edema. Eating watermelon can promote an increase in urine output, thereby helping to alleviate edema.

doctor image
home-news-image
Written by Liu Liang
Oncology
37sec home-news-image

Is there still a cure for pancreatic cancer with liver metastasis?

Pancreatic cancer with liver metastasis is considered to be in the advanced stage, but some patients can still benefit from treatment in terms of survival. They can choose chemotherapy, targeted therapy, and oral anti-angiogenesis medications, among others. The choice of specific medications should take into account the patient's overall condition and various other factors. The effectiveness of the treatment varies from person to person; some patients may benefit from the treatment, while others may not see significant improvement, but these options are still worth considering.